.

Walter helps life sciences companies build patent portfolios that support growth, financing, and exit strategies, and helps investors evaluate patent assets in acquisitions, financings, and other strategic transactions.

Walter advises life sciences and healthcare technology companies on patent prosecution, patent portfolio development, and intellectual property strategy. He helps emerging companies align their patent portfolios with business objectives, financing goals, commercialization plans, and potential exit opportunities. He also counsels investors, acquirers, and strategic partners on patent due diligence for acquisitions, investments, and other transactions involving IP-intensive businesses.

His clients operate across digital health, medical diagnostics, bioinformatics, ophthalmic devices, wound care, and ENT technologies, where strong patent protection can be a critical driver of company valuation, investment readiness, and competitive advantage.

Walter brings a perspective few patent attorneys can offer. He holds a medical degree, is a licensed physician, and was board-certified in internal medicine from 2000 to 2010. His clinical training enables him to quickly understand complex medical technologies, evaluate patent claims in the context of real-world healthcare applications, and identify strengths and vulnerabilities that may affect patent value, freedom to operate, or investment risk.

In addition to patent prosecution and portfolio counseling, Walter develops intellectual property strategies for inter partes review (IPR) proceedings, patent litigation, and other patent disputes. His experience includes matters involving surgical robotics, prosthetic devices, and pharmaceutical technologies, where he has applied his medical and biostatistical background to analyze highly technical issues.

Walter regularly conducts patent due diligence for investors and strategic buyers evaluating healthcare and technology companies. His experience includes assessing patent portfolios involving internet-connected glucometers and inhalers, accommodating intraocular lenses, and cloud-based genomics analysis platforms. He has also advised emerging companies on patent strategies that helped position them for successful acquisitions and other strategic opportunities.

Select Experience

  • Advised on patent prosecution and portfolio strategy for Jenesis Surgical prior to its acquisition by Edwards Lifesciences Corp.
  • Advised on patent prosecution and portfolio strategy for Spiracur Inc. prior to its acquisition by KCI Licensing, Inc.
  • Provided patent strategy support in connection with Alcon's licensing of the Google Smart Lens technology, a cross-sector ophthalmic and digital health transaction.
  • Provided patent strategy support in connection with Auris Surgical Robotics' acquisition of Hansen Medical, involving surgical robotics patent considerations.

Education

  • University of California, Los Angeles (UCLA) (J.D., 2003)
    • Co-Chief Resident
    • Internal Medicine (2000)
    • Internal Medicine Residence (1999)
  • University of California, Davis (M.D., 1996)
  • University of California, Los Angeles (UCLA) (B.S., 1991)

Bar Admissions

  • California
  • United States Patent and Trademark Office

Charitable & Civic Involvement

  • Project Evaluation Committee member, MedTech Catapult, the Agency for Science, Technology and Research, Singapore (A*STAR)
  • Industry contributor/mentor, Stanford Biodesign
    • Faculty Fellowship
    • Biodesign Innovation program
  • Volunteer team supervisor, UC Hastings StartUp Legal Garage
  • CleanTechOpen, Regional Judge and Mentor

Accolades

  • Consistently providing pro bono legal assistance to those in need through Dorsey’s Pro Bono program
  • Dorsey & Whitney – Scales of Justice Team Award (Veterans Rights Team), 2025
  • Recognized in Lawyers of Color's Power List, 2020

Select Presentations

  • Speaker, Critical IP Questions for Cleantech Entrepreneurs during Investor Due Diligence, CleanTechOpen Western Region (March and April 2024) 
  • Speaker, Patent Strategy: How to Draft a Patent Application, Singapore Biodesign
  • Panelist, Section 112/Means Plus Function Claiming, Berkeley - Stanford Advanced Patent Law Institute: Silicon Valley (December 2016)
  • Speaker, Connections and Collaborations: High Tech + Life Sciences, Life Sciences Seminar Series (January 2015)
  • Speaker, OneStart Biotech Boot Camp, Oxbridge Biotech Roundtable (February 2014)
  • Speaker, Medtech Ventures: Cross-Border Investment and Partnering Trends – Intellectual Property Development, ITRI-Biodesign Alumni Association (October 2013)
  • Moderator, The Future of Health & Medicine: Where Can Technology Take Us? SARTA (May 2013)
  • Panelist, Intellectual Property and the In-House Lawyer: Current Issues and Strategies, USC Gould School of Law’s Annual Institute for Corporate Counsel (December 2012)
  • Speaker, Medical Devices: Current Trends, Patent Strategy & IP Due Diligence, ITRI (December 2012)
  • Moderator, Roll Out Your Mobile Apps for Health & Fitness, Silicon Valley-China Wireless Technology Association (May 2012)

Firm Highlights